Dr Kari Martha Visser-robel, OD | |
713 S Wisconsin Ave, Gaylord, MI 49735-1766 | |
(989) 705-1255 | |
(989) 705-1476 |
Full Name | Dr Kari Martha Visser-robel |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 30 Years |
Location | 713 S Wisconsin Ave, Gaylord, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164425666 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 4901003735 (Michigan) | Primary |
Provider Name | Kari Visser Robel Od Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1740361427 PECOS PAC ID: 3274534383 Enrollment ID: O20070116000229 |
News Archive
Molecular and serum markers of prognosis in renal cell carcinoma have remained elusive. In large part, tumor (TNM) stage, Fuhrman grade, and patient performance status have stood the test of time as the most valuable factors in predicting patient outcome following surgery.
An innovative interventional radiology treatment for men with enlarged prostates decreases the number of times they wake to urinate in the night, according to research presented at the Society of Interventional Radiology's 2016 Annual Scientific Meeting. Researchers said the majority of men with enlarged prostates and lower urinary tract symptoms reported better sleep that resulted in an improved quality of life after they underwent a treatment called prostatic artery embolization (PAE).
A study by researchers at the University of California, San Diego School of Medicine shows there is increasing evidence that high rates of illness in Persian Gulf War Veterans can be explained, in part, by exposure to certain chemicals, including pesticides and nerve agents.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kari Martha Visser-robel, OD Po Box 1220, Gaylord, MI 49734-5220 Ph: (989) 705-1255 | Dr Kari Martha Visser-robel, OD 713 S Wisconsin Ave, Gaylord, MI 49735-1766 Ph: (989) 705-1255 |
News Archive
Molecular and serum markers of prognosis in renal cell carcinoma have remained elusive. In large part, tumor (TNM) stage, Fuhrman grade, and patient performance status have stood the test of time as the most valuable factors in predicting patient outcome following surgery.
An innovative interventional radiology treatment for men with enlarged prostates decreases the number of times they wake to urinate in the night, according to research presented at the Society of Interventional Radiology's 2016 Annual Scientific Meeting. Researchers said the majority of men with enlarged prostates and lower urinary tract symptoms reported better sleep that resulted in an improved quality of life after they underwent a treatment called prostatic artery embolization (PAE).
A study by researchers at the University of California, San Diego School of Medicine shows there is increasing evidence that high rates of illness in Persian Gulf War Veterans can be explained, in part, by exposure to certain chemicals, including pesticides and nerve agents.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
› Verified 7 days ago
Pierce Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 950 Edelweiss Parkway, Gaylord, MI 49735 Phone: 989-732-5233 Fax: 989-732-5344 | |
Dr. Roxanne Rottiers, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 350 W North St, Gaylord, MI 49735 Phone: 989-732-6455 | |
Alpine Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 350 W North St, Gaylord, MI 49735 Phone: 989-732-6455 Fax: 989-732-1102 | |
Kleinebreil Optometry Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 927 S Otsego Ave, Gaylord, MI 49735 Phone: 989-732-7518 Fax: 989-732-4205 | |
Dr. Bailey Elise Pearson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 713 S Wisconsin Ave, Gaylord, MI 49735 Phone: 989-705-1255 | |
William Roy Shouldice, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 350 W North St, Gaylord, MI 49735 Phone: 989-732-6455 Fax: 989-732-1102 |